D'Orazio & Associates, Inc. Pfizer Inc Transaction History

D'Orazio & Associates, Inc.

$619 Million
Q1 2024

A detailed history of D'Orazio & Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, D'Orazio & Associates, Inc. holds 7,631 shares of PFE stock, worth $214,049. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,631

Previous 7,873 3.07%

Holding current value

$214,049

Previous $226,000 6.64%

% of portfolio

0.03%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $6,265 - $7,194	-242 Reduced 3.07%	7,631 $211,000
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $17,324 - $22,502	-663 Reduced 7.77%	7,873 $226,000
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $45,439 - $53,114	-1,416 Reduced 14.23%	8,536 $283,000
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $131,946 - $152,658	3,653 Added 57.99%	9,952 $365,000
Q1 2023 Apr 21, 2023	SELL	$39.39 - $51.28 $84,018 - $109,380	-2,133 Reduced 25.3%	6,299 $256,000

Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $94,689 - $123,606	-2,268 Reduced 21.2%	8,432 $0
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $64,721 - $79,008	1,479 Added 16.04%	10,700 $468,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $48,484 - $57,487	1,042 Added 12.74%	9,221 $483,000
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $21,273 - $26,360	465 Added 6.03%	8,179 $423,000
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $38,799 - $57,513	939 Added 13.86%	7,714 $456,000
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $21,273 - $27,327	542 Added 8.7%	6,775 $291,000
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $25,783 - $29,208	718 Added 13.02%	6,233 $244,000
Q1 2021 May 05, 2021	SELL	$33.49 - $37.77 $8,339 - $9,404	-249 Reduced 4.32%	5,515 $200,000
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $3,012 - $3,830	-90 Reduced 1.54%	5,764 $212,000
Q3 2020 Oct 19, 2020	BUY	$31.75 - $37.25 $5,143 - $6,034	162 Added 2.85%	5,854 $215,000
Q2 2020 Jul 22, 2020	BUY	$30.12 - $36.54 $481 - $584	16 Added 0.28%	5,692 $186,000
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $72,413 - $103,462	-2,679 Reduced 32.06%	5,676 $185,000
Q4 2019 Jan 22, 2020	BUY	$32.92 - $37.36 $987 - $1,120	30 Added 0.36%	8,355 $327,000
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $13,353 - $17,315	411 Added 5.19%	8,325 $299,000
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $5,029 - $5,646	-136 Reduced 1.69%	7,914 $343,000
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $7,050 - $7,745	188 Added 2.39%	8,050 $342,000
Q4 2018 Jan 24, 2019	BUY	$38.47 - $43.86 $39,239 - $44,737	1,020 Added 14.91%	7,862 $343,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $861 - $1,045	25 Added 0.37%	6,842 $302,000
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $2,440 - $2,601	-74 Reduced 1.07%	6,817 $247,000
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $4,180 - $4,849	131 Added 1.94%	6,891 $245,000
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $38,315 - $40,654	1,152 Added 20.54%	6,760 $245,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $173,848 - $191,513	5,608	5,608 $200,000

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D'Orazio & Associates, Inc. with notifications on news.

Account

D'Orazio & Associates, Inc. Pfizer Inc Transaction History